Literature DB >> 25005454

Incidence, predictors, and clinical course of atrial tachyarrhythmias in patients with pulmonary hypertension.

Arun Kanmanthareddy1, Yeruva Madhu Reddy, Hemant Boolani, Sowjanya Duthuluru, Jayasree Pillarisetti, Ajay Vallakati, Sudharani Bommana, Donita Atkins, Timothy Williamson, Dhanunjaya Lakkireddy.   

Abstract

BACKGROUND: The prevalence and predictors of atrial tachyarrhythmias (ATa) in patients with pulmonary hypertension (PH) is less well understood.
METHODS: We performed a retrospective study including 311 patients with PH, confirmed by right heart catheterization in our center between 2007 and 2011. Baseline characteristics, clinical, echocardiographic, and hemodynamic data were collected and compared between patients with and without ATa.
RESULTS: The mean age was 61 ± 13 years with 64 % females. The mean pulmonary artery pressure (mPAP) was 46 ± 20 mmHg, mean left ventricular ejection fraction (LVEF) was 55 ± 13 %, and mean pulmonary capillary wedge pressure (PCWP) was 19 ± 9 mmHg. Of the 311 patients with PH, 121 (39 %) patients had ATa. Patients with ATa were older (p<0.001) and were more likely to have systemic hypertension (p=0.03), diabetes (p=0.015), coronary artery disease (p<0.001), heart failure (p<0.001), mitral regurgitation (p=0.001), impaired LVEF (p=0.02), and left atrial enlargement (p<0.001). There was no difference in the prevalence of ATa in mild, moderate, or severe PH. The mean PCWP was higher in patients with ATa (17.9 ± 9 vs 20.3 ± 8; p=0.022). In multivariate analysis using Cox-proportional hazard model, the independent predictors of mortality were age (HR 1.05; p=0.003), coronary artery disease (HR 2.34; p=0.047), LVEF (HR 0.793; p=0.023), and mPAP (HR 1.023; p=0.003).
CONCLUSION: ATa are common in patients with PH. Left heart disease, left atrial enlargement, and elevated PCWP but not right atrial enlargement or mPAP predict the occurrence of ATa in patients with PH.

Entities:  

Mesh:

Year:  2014        PMID: 25005454     DOI: 10.1007/s10840-014-9928-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  16 in total

Review 1.  Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.

Authors:  Yong-Mei Cha; Margaret M Redfield; Win-Kuang Shen; Bernard J Gersh
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 2.  The right ventricle in pulmonary hypertension.

Authors:  Kelly M Chin; Nick H S Kim; Lewis J Rubin
Journal:  Coron Artery Dis       Date:  2005-02       Impact factor: 1.439

3.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation.

Authors:  D M Clark; V J Plumb; A E Epstein; G N Kay
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

Review 4.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

5.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 6.  Arrhythmias in pulmonary arterial hypertension.

Authors:  Archana Rajdev; Hasan Garan; Angelo Biviano
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

7.  Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension.

Authors:  A F Folino; F Bobbo; C Schiraldi; F Tona; S Romano; G Buja; F Bellotto
Journal:  Lung       Date:  2003 Nov-Dec       Impact factor: 2.584

8.  Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction.

Authors:  D L Packer; G H Bardy; S J Worley; M S Smith; F R Cobb; R E Coleman; J J Gallagher; L D German
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

9.  Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances.

Authors:  Laurent Fauchier; Dominique Babuty; Alexandre Melin; Pierre Bonnet; Pierre Cosnay; Jean Paul Fauchier
Journal:  Eur J Heart Fail       Date:  2004-03-01       Impact factor: 15.534

10.  Clinical impact of atrial fibrillation in patients with pulmonary hypertension.

Authors:  Dennis Rottlaender; Lukas J Motloch; Daniela Schmidt; Sara Reda; Robert Larbig; Martin Wolny; Daniel Dumitrescu; Stephan Rosenkranz; Erland Erdmann; Uta C Hoppe
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  4 in total

Review 1.  [Arrhythmias in patients with pulmonary hypertension and chronic lung disease].

Authors:  Dirk Bandorski; Reinhard Höltgen; Ardeschir Ghofrani; Viktoria Johnson; Jörn Schmitt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

2.  Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.

Authors:  Brett Wanamaker; Thomas Cascino; Vallerie McLaughlin; Hakan Oral; Rakesh Latchamsetty; Konstantinos C Siontis
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

3.  Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact.

Authors:  Valentina Mercurio; Grace Peloquin; Khalil I Bourji; Nermin Diab; Takahiro Sato; Blessing Enobun; Traci Housten-Harris; Rachel Damico; Todd M Kolb; Stephen C Mathai; Ryan J Tedford; Carlo G Tocchetti; Paul M Hassoun
Journal:  Pulm Circ       Date:  2018-03-26       Impact factor: 3.017

4.  Left atrial ablation for the management of atrial tachyarrhythmias in patients with pulmonary hypertension: A case series.

Authors:  Thomas A Boyle; Usama A Daimee; Catherine E Simpson; Todd M Kolb; Stephen C Mathai; Tauseef Akhtar; Daniel Nyhan; Hugh Calkins; David Spragg
Journal:  HeartRhythm Case Rep       Date:  2022-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.